Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German males eschew cancer screening:

This article was originally published in Clinica

Executive Summary

Only 19.7% of German males entitled to receive cancer screening under their sickness insurance fund actually make use of the option, according to federal ministry for health and social security (BMGS). Men aged 45 and over are entitled to prostate, testicular and skin cancer screening annually. From 55, they are entitled to have a faecal occult blood test (FOBT).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel